German Biotechnology Transfer System Outshines US, Revolutionizing Global Innovation Market.
The article discusses how technology transfer in Germany is more efficient than in the United States, helping them gain a competitive advantage in biotechnology. In the US, policymakers either intervene to support specific industries or believe in letting the free market decide. Germany focuses on commercializing technology, while the US relies on small companies to bring new technologies to market.